Genomate Health
Health and Human ServicesMassachusetts, United States11-50 Employees
Genomate Health is a medical technology company based in Cambridge, Massachusetts, focused on developing computational models that integrate published scientific evidence and clinical experience with reasoning processes to guide cancer treatment. Its flagship product, Genomate, is described as an AI-driven solution that automates the compilation and synthesis of molecular information to support personalized, N-of-1 treatment decisions in precision oncology. The company operates in the Health and Human Services industry and collaborates with cancer centers, diagnostic companies, insurance entities, health funds, and pharmaceutical firms to broaden access to targeted cancer therapies. Based in the Cambridge area, Genomate Health emphasizes precision medicine and computational reasoning to tailor therapy to individual disease profiles. The firm has pursued strategic growth through acquisitions and expansion into the U.S. market, including recent activity related to the Oncompass Medicine acquisition and the launch of an AI-powered second opinion service for physicians. The organization serves a global oncology ecosystem by aligning multiple stakeholders around personalized treatment options.